Natixis Co Diagnostics, Inc. Transaction History

Natixis

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$7.48 - $11.38 $104,720 - $159,320	-14,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$7.16 - $9.56 $21,480 - $28,680	3,000 Added 27.27%	14,000 $116,000
Q1 2021 May 14, 2021	SELL	$8.52 - $19.21 $14,484 - $32,657	-1,700 Reduced 13.39%	11,000 $105,000
Q4 2020 Feb 12, 2021	SELL	$9.3 - $15.19 $62,310 - $101,773	-6,700 Reduced 34.54%	12,700 $118,000
Q3 2020 Nov 12, 2020	BUY	$8.24 - $30.8 $159,856 - $597,520	19,400 New	19,400 $264,000

4.26M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $37.2M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.